Literature DB >> 23552894

HIV: Roadmaps to a vaccine.

Hugo Mouquet, Michel C Nussenzweig.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23552894     DOI： 10.1038/nature12091

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strains.

Authors:  Masashi Shingai; Olivia K Donau; Stephen D Schmidt; Rajeev Gautam; Ronald J Plishka; Alicia Buckler-White; Reza Sadjadpour; Wendy R Lee; Celia C LaBranche; David C Montefiori; John R Mascola; Yoshiaki Nishimura; Malcolm A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

Review 2.  Broadly neutralizing antiviral antibodies.

Authors:  Davide Corti; Antonio Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2013-01-16       Impact factor: 28.527

3.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

Authors:  Barton F Haynes; Peter B Gilbert; M Juliana McElrath; Susan Zolla-Pazner; Georgia D Tomaras; S Munir Alam; David T Evans; David C Montefiori; Chitraporn Karnasuta; Ruengpueng Sutthent; Hua-Xin Liao; Anthony L DeVico; George K Lewis; Constance Williams; Abraham Pinter; Youyi Fong; Holly Janes; Allan DeCamp; Yunda Huang; Mangala Rao; Erik Billings; Nicos Karasavvas; Merlin L Robb; Viseth Ngauy; Mark S de Souza; Robert Paris; Guido Ferrari; Robert T Bailer; Kelly A Soderberg; Charla Andrews; Phillip W Berman; Nicole Frahm; Stephen C De Rosa; Michael D Alpert; Nicole L Yates; Xiaoying Shen; Richard A Koup; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Nelson L Michael; Jerome H Kim
Journal:  N Engl J Med       Date:  2012-04-05       Impact factor: 91.245

4.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

5.  Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation.

Authors:  Hugo Mouquet; Johannes F Scheid; Markus J Zoller; Michelle Krogsgaard; Rene G Ott; Shetha Shukair; Maxim N Artyomov; John Pietzsch; Mark Connors; Florencia Pereyra; Bruce D Walker; David D Ho; Patrick C Wilson; Michael S Seaman; Herman N Eisen; Arup K Chakraborty; Thomas J Hope; Jeffrey V Ravetch; Hedda Wardemann; Michel C Nussenzweig
Journal:  Nature       Date:  2010-09-30       Impact factor: 49.962

6.  Rational HIV immunogen design to target specific germline B cell receptors.

Authors:  Joseph Jardine; Jean-Philippe Julien; Sergey Menis; Takayuki Ota; Oleksandr Kalyuzhniy; Andrew McGuire; Devin Sok; Po-Ssu Huang; Skye MacPherson; Meaghan Jones; Travis Nieusma; John Mathison; David Baker; Andrew B Ward; Dennis R Burton; Leonidas Stamatatos; David Nemazee; Ian A Wilson; William R Schief
Journal:  Science       Date:  2013-03-28       Impact factor: 47.728

7.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

8.  Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape.

Authors:  Penny L Moore; Elin S Gray; C Kurt Wibmer; Jinal N Bhiman; Molati Nonyane; Daniel J Sheward; Tandile Hermanus; Shringkhala Bajimaya; Nancy L Tumba; Melissa-Rose Abrahams; Bronwen E Lambson; Nthabeleng Ranchobe; Lihua Ping; Nobubelo Ngandu; Quarraisha Abdool Karim; Salim S Abdool Karim; Ronald I Swanstrom; Michael S Seaman; Carolyn Williamson; Lynn Morris
Journal:  Nat Med       Date:  2012-10-21       Impact factor: 53.440

9.  HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.

Authors:  Ariel Halper-Stromberg; Joshua A Horwitz; Florian Klein; Henning Gruell; Johannes F Scheid; Stylianos Bournazos; Hugo Mouquet; Linda A Spatz; Ron Diskin; Alexander Abadir; Trinity Zang; Marcus Dorner; Eva Billerbeck; Rachael N Labitt; Christian Gaebler; Paola Marcovecchio; Reha-Baris Incesu; Thomas R Eisenreich; Paul D Bieniasz; Michael S Seaman; Pamela J Bjorkman; Jeffrey V Ravetch; Alexander Ploss; Michel C Nussenzweig
Journal:  Nature       Date:  2012-10-24       Impact factor: 49.962

10.  Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.

Authors:  Hua-Xin Liao; Rebecca Lynch; Tongqing Zhou; Feng Gao; S Munir Alam; Scott D Boyd; Andrew Z Fire; Krishna M Roskin; Chaim A Schramm; Zhenhai Zhang; Jiang Zhu; Lawrence Shapiro; James C Mullikin; S Gnanakaran; Peter Hraber; Kevin Wiehe; Garnett Kelsoe; Guang Yang; Shi-Mao Xia; David C Montefiori; Robert Parks; Krissey E Lloyd; Richard M Scearce; Kelly A Soderberg; Myron Cohen; Gift Kamanga; Mark K Louder; Lillian M Tran; Yue Chen; Fangping Cai; Sheri Chen; Stephanie Moquin; Xiulian Du; M Gordon Joyce; Sanjay Srivatsan; Baoshan Zhang; Anqi Zheng; George M Shaw; Beatrice H Hahn; Thomas B Kepler; Bette T M Korber; Peter D Kwong; John R Mascola; Barton F Haynes
Journal:  Nature       Date:  2013-04-03       Impact factor: 49.962
View more
  17 in total

Review 1.  Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.

Authors:  Ivelin S Georgiev; M Gordon Joyce; Tongqing Zhou; Peter D Kwong
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

2.  Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.

Authors:  Ujjwal Rathore; Piyali Saha; Sannula Kesavardhana; Aditya Arun Kumar; Rohini Datta; Sivasankar Devanarayanan; Raksha Das; John R Mascola; Raghavan Varadarajan
Journal:  J Biol Chem       Date:  2017-04-26       Impact factor: 5.157

Review 3.  Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors:  Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

4.  Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1.

Authors:  Colin LaMont; Jakub Otwinowski; Kanika Vanshylla; Henning Gruell; Florian Klein; Armita Nourmohammad
Journal:  Elife       Date:  2022-07-19       Impact factor: 8.713

5.  High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.

Authors:  Christopher J A Duncan; James P Williams; Torben Schiffner; Kathleen Gärtner; Christina Ochsenbauer; John Kappes; Rebecca A Russell; John Frater; Quentin J Sattentau
Journal:  J Virol       Date:  2013-12-04       Impact factor: 5.103

6.  Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.

Authors:  Hannah J Barbian; Julie M Decker; Frederic Bibollet-Ruche; Rachel P Galimidi; Anthony P West; Gerald H Learn; Nicholas F Parrish; Shilpa S Iyer; Yingying Li; Craig S Pace; Ruijiang Song; Yaoxing Huang; Thomas N Denny; Hugo Mouquet; Loic Martin; Priyamvada Acharya; Baoshan Zhang; Peter D Kwong; John R Mascola; C Theo Verrips; Nika M Strokappe; Lucy Rutten; Laura E McCoy; Robin A Weiss; Corrine S Brown; Raven Jackson; Guido Silvestri; Mark Connors; Dennis R Burton; George M Shaw; Michel C Nussenzweig; Pamela J Bjorkman; David D Ho; Michael Farzan; Beatrice H Hahn
Journal:  MBio       Date:  2015-04-21       Impact factor: 7.867

Review 7.  Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens.

Authors:  Quentin J Sattentau
Journal:  Vaccines (Basel)       Date:  2013-10-28

Review 8.  Development of prophylactic vaccines against HIV-1.

Authors:  Torben Schiffner; Quentin J Sattentau; Lucy Dorrell
Journal:  Retrovirology       Date:  2013-07-17       Impact factor: 4.602

9.  Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS.

Authors:  Mark Page; Ruby Quartey-Papafio; Mark Robinson; Mark Hassall; Martin Cranage; James Stott; Neil Almond
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

Review 10.  Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1.

Authors:  Lei Yu; Yongjun Guan
Journal:  Front Immunol       Date:  2014-06-02       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.